Cellid, Co., Ltd. (KOSDAQ:299660)
South Korea
· Delayed Price · Currency is KRW 5,810.00
-220.00 (-3.65%)
Jun 19, 2025, 3:30 PM KST
Cellid, Revenue
In the year 2024, Cellid, had annual revenue of 4.17B KRW. Cellid, had revenue of 1.88B in the quarter ending December 31, 2024.
Revenue
4.17B
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
122.61B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,898.69B |
| Celltrion | 3,662.23B |
| ALTEOGEN | 151.65B |
| Yuhan | 2,114.76B |
| SK Biopharmaceuticals | 578.00B |
| HLB Co., Ltd. | 74.64B |
| Peptron | 4.30B |
| PharmaResearch | 392.31B |